Details of Bacterial Vaccine
This bacterial vaccine card gives comprehensive information about each vaccine.
Detailed Information | |
---|---|
ID | 1366 |
Name of the vaccine | rPA-102 |
Microbe | Bacteria |
Disease name | Anthrax |
Name of bacteria | Bacillus anthracis |
Type of vaccine | Recombinant |
Nucleic acid content | Linear DNA |
Age | 18 to 55 years |
Description of the vaccine | NA |
Name of the manufacturer | VaxGen |
Name of the manufacturing country | United States |
Year of manufacture | 2005 |
Clinical Phase status | Clinical - Phase 2 |
Bacterial strain | Gram-positive, rod-shaped bacteria. |
Efficacy | NA |
Vaccine formulation | Suspension for injection |
Dosage | Two doses at 0 and 4 weeks. |
Mechanism of action | NA |
Route of administration | Intramuscular |
Indications | NA |
Export | NA |
Approval | NA |
Adjuvant | Yes |
Repurposing | NA |
Side effects of vaccine | NA |
Post vaccination | NA |
Dose type | Combination doses |
Interspecies transfer | Yes (Zoonotic disease through contact with an infected animal or by inhaling spores) |
PubMed identifier | NA |
Clinical trial number | NCT00100724 |
Reference | NA |
Other name | NA |
Additional Links | NA |